ALLERGOLOGIE is a prominent academic journal dedicated to the field of immunology and allergy, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany. Since its inception in 1978, the journal has provided a vital platform for researchers, clinicians, and students to disseminate their findings, share insights, and foster advancements in the understanding of allergic diseases and immunological responses. With an ISSN of 0344-5062 and an E-ISSN of the same number, it is a respected source within its category, currently ranked in the 2023 Q4 of the Scopus metrics in immunology and allergy, reflecting its commitment to quality and scholarly rigor. Although not fully open access, ALLERGOLOGIE makes significant contributions to the dialogue on allergy-related topics, encouraging engagement from its readership through a diverse array of articles that span from clinical trials to innovative research methods. This journal continues to be an essential resource for anyone involved in the pursuit of knowledge in allergy and immunology.

The Revue Francaise d'Allergologie, an esteemed publication in the field of Immunology and Allergy, is published by ELSEVIER MASSON, CORP OFF in France. This journal plays a pivotal role in disseminating significant findings and advancements in allergy research and immunotherapy, reflecting the latest trends and challenges in these rapidly evolving areas. As part of its commitment to scholarly rigor, the journal encompasses a wide range of topics pertinent to allergology, aiming to bridge the gap between clinical practice and academic research. Although currently not listed as open access, it provides critical insights essential for researchers, professionals, and students alike, ensuring the advancement of knowledge and therapeutic strategies in allergy and immunology. With its impact factor and positioning in the Q4 category, it serves as a valuable resource, aiding in the education and development of future leaders in the field. The Revue Francaise d'Allergologie continues to be a vital platform for the exchange of innovative ideas and findings from 2009 to the present.

Dermatitis, published by MARY ANN LIEBERT, INC, is a leading journal that focuses on the study of skin inflammation and allergic reactions, making significant contributions to the fields of Dermatology, Immunology, and Allergy. With an ISSN of 1710-3568 and an E-ISSN of 2162-5220, this peer-reviewed journal serves as a critical platform for researchers, healthcare professionals, and students alike, eager to share and explore groundbreaking findings and developments. Recognized for its impact and rigorous scholarly standards, Dermatitis has achieved a Q2 quartile ranking in dermatology and a Q3 ranking in immunology and allergy as of 2023, underscoring its significance in these vital medical sectors. The journal's Scopus ranking places it in the 84th percentile for dermatology and the 50th percentile for immunology and allergy, reflecting its wide acceptance and influence. With a scope spanning from 2004 to 2024, Dermatitis invites original research, reviews, and clinical updates that advance the understanding of skin disorders and therapy innovations, solidifying its role as an essential resource in enhancing skin health worldwide.

Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

CLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.

Frontiers in Allergy is a pioneering open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the frontiers of research in the fields of Immunology and Infectious Diseases. Launched in 2020 and based in Lausanne, Switzerland, this journal provides a dynamic platform for researchers, professionals, and students to share innovative findings and insights related to allergic disorders and their broader immunological implications. With a respectable Q2 ranking in both Immunology and Allergy and Infectious Diseases categories, as well as being indexed in Scopus, this journal is emerging as a significant resource for the scientific community. The open-access model ensures wide dissemination of valuable knowledge, facilitating collaboration and breakthroughs in treatments and understanding of allergies and related conditions. Frontiers in Allergy invites contributions that drive forward the understanding of immune responses, allergy prevention, and management, solidifying its role as a crucial player in the sustainability and growth of health sciences.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.

Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.

The Journal of Allergy and Clinical Immunology-In Practice, published by ELSEVIER, stands as a leading platform in the field of allergy and immunology, specifically tailored for practitioners and researchers. With an impressive 2023 Q1 ranking in both the Immunology and Allergy categories, this journal demonstrates a significant impact within the academic community, evidenced by its Scopus rank #41 out of 233 and an impressive percentile rank of 82. The journal focuses on providing advanced studies, clinical findings, and innovative treatment methodologies that address current challenges in allergy and immunology, making it a vital resource for professionals in these fields. With a comprehensive coverage of relevant topics from 2013 to 2024, the journal continues to evolve alongside emerging trends and developments in clinical practice, fostering an environment conducive to scholarly research and application. Although it currently does not offer open access, authors and readers can access a wealth of information and contribute to ongoing dialogues through its robust publication platform.